These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
94-3180138
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
ý
|
|
|
|
|
|
|||
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller Reporting Company
|
|
¨
|
|
|
|
|
|
Emerging Growth Company
|
|
¨
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
Item 1.
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
|
June 30, 2017
|
|
December 31, 2016
|
||||
|
ASSETS
|
|
|
|
|
||||
|
Current assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
33,152
|
|
|
$
|
56,865
|
|
|
Short-term investments
|
|
28,863
|
|
|
32,907
|
|
||
|
Accounts and other receivables (net of allowances for doubtful accounts of $6, and $0, respectively)
|
|
3,335
|
|
|
1,382
|
|
||
|
Prepaid expenses and other current assets
|
|
989
|
|
|
2,876
|
|
||
|
Total current assets
|
|
66,339
|
|
|
94,030
|
|
||
|
Property and equipment, net
|
|
3,638
|
|
|
4,016
|
|
||
|
Deferred income tax assets
|
|
437
|
|
|
359
|
|
||
|
Prepaid income taxes
|
|
—
|
|
|
4,997
|
|
||
|
Intangibles and other assets, net
|
|
363
|
|
|
365
|
|
||
|
Total assets
|
|
$
|
70,777
|
|
|
$
|
103,767
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
10,237
|
|
|
$
|
5,951
|
|
|
Accrued compensation
|
|
2,355
|
|
|
4,753
|
|
||
|
Other current liabilities
|
|
3,886
|
|
|
4,409
|
|
||
|
Deferred revenue
|
|
5,004
|
|
|
5,909
|
|
||
|
Total current liabilities
|
|
21,482
|
|
|
21,022
|
|
||
|
Long-term deferred revenue
|
|
24,369
|
|
|
26,393
|
|
||
|
Other long-term liabilities
|
|
963
|
|
|
1,012
|
|
||
|
Total liabilities
|
|
46,814
|
|
|
48,427
|
|
||
|
Contingencies (Note 12)
|
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
|
|
||||
|
Common stock and additional paid-in capital — $0.001 par value; 100,000,000 shares authorized; 35,891,850 and 35,555,562 shares issued, respectively; 29,253,847 and 28,917,559 shares outstanding, respectively
|
|
224,451
|
|
|
221,098
|
|
||
|
Accumulated other comprehensive income
|
|
91
|
|
|
115
|
|
||
|
Accumulated deficit
|
|
(154,035
|
)
|
|
(119,329
|
)
|
||
|
Treasury stock at cost: 6,638,003 shares
|
|
(46,544
|
)
|
|
(46,544
|
)
|
||
|
Total stockholders’ equity
|
|
23,963
|
|
|
55,340
|
|
||
|
Total liabilities and stockholders’ equity
|
|
$
|
70,777
|
|
|
$
|
103,767
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|
||||||||
|
Royalty and license
|
|
$
|
6,785
|
|
|
$
|
7,615
|
|
|
$
|
15,791
|
|
|
$
|
21,063
|
|
|
Development, services, and other
|
|
245
|
|
|
249
|
|
|
463
|
|
|
424
|
|
||||
|
Total revenues
|
|
7,030
|
|
|
7,864
|
|
|
16,254
|
|
|
21,487
|
|
||||
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
||||||||
|
Cost of revenues
|
|
54
|
|
|
61
|
|
|
97
|
|
|
87
|
|
||||
|
Sales and marketing
|
|
3,461
|
|
|
3,397
|
|
|
6,766
|
|
|
7,200
|
|
||||
|
Research and development
|
|
2,826
|
|
|
2,966
|
|
|
6,022
|
|
|
7,278
|
|
||||
|
General and administrative
|
|
15,600
|
|
|
11,001
|
|
|
31,132
|
|
|
21,091
|
|
||||
|
Total costs and expenses
|
|
21,941
|
|
|
17,425
|
|
|
44,017
|
|
|
35,656
|
|
||||
|
Operating loss
|
|
(14,911
|
)
|
|
(9,561
|
)
|
|
(27,763
|
)
|
|
(14,169
|
)
|
||||
|
Interest and other income
|
|
165
|
|
|
33
|
|
|
304
|
|
|
245
|
|
||||
|
Loss from continuing operations before benefit (provision) for income taxes
|
|
(14,746
|
)
|
|
(9,528
|
)
|
|
(27,459
|
)
|
|
(13,924
|
)
|
||||
|
Benefit (provision) for income taxes
|
|
(99
|
)
|
|
3,323
|
|
|
(251
|
)
|
|
5,024
|
|
||||
|
Loss from continuing operations
|
|
(14,845
|
)
|
|
(6,205
|
)
|
|
(27,710
|
)
|
|
(8,900
|
)
|
||||
|
Income from discontinued operations, net of tax
|
|
—
|
|
|
649
|
|
|
—
|
|
|
649
|
|
||||
|
Net loss
|
|
$
|
(14,845
|
)
|
|
$
|
(5,556
|
)
|
|
$
|
(27,710
|
)
|
|
$
|
(8,251
|
)
|
|
Basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
||||||||
|
Continuing operations
|
|
(0.51
|
)
|
|
(0.22
|
)
|
|
(0.95
|
)
|
|
(0.31
|
)
|
||||
|
Discontinued operations
|
|
—
|
|
|
0.02
|
|
|
—
|
|
|
0.02
|
|
||||
|
Total
|
|
$
|
(0.51
|
)
|
|
$
|
(0.20
|
)
|
|
$
|
(0.95
|
)
|
|
$
|
(0.29
|
)
|
|
Shares used in calculating basic and diluted net loss per share
|
|
29,193
|
|
|
28,834
|
|
|
29,109
|
|
|
28,663
|
|
||||
|
Other comprehensive income (loss), net of tax
|
|
|
|
|
|
|
|
|
||||||||
|
Change in unrealized gains (losses) on short-term investments
|
|
(2
|
)
|
|
23
|
|
|
(24
|
)
|
|
55
|
|
||||
|
Total other comprehensive income (loss)
|
|
(2
|
)
|
|
23
|
|
|
(24
|
)
|
|
55
|
|
||||
|
Total comprehensive loss
|
|
$
|
(14,847
|
)
|
|
$
|
(5,533
|
)
|
|
$
|
(27,734
|
)
|
|
$
|
(8,196
|
)
|
|
|
|
Six Months Ended June 30,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Cash flows used in operating activities:
|
|
|
|
|
||||
|
Net loss
|
|
$
|
(27,710
|
)
|
|
$
|
(8,251
|
)
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
||||
|
Depreciation and amortization of property and equipment
|
|
469
|
|
|
448
|
|
||
|
Amortization of intangibles
|
|
—
|
|
|
5
|
|
||
|
Stock-based compensation
|
|
2,735
|
|
|
3,589
|
|
||
|
Deferred income taxes
|
|
(77
|
)
|
|
(6,472
|
)
|
||
|
Allowance for doubtful accounts
|
|
6
|
|
|
2
|
|
||
|
Income from discontinued operations
|
|
—
|
|
|
(649
|
)
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
||||
|
Accounts and other receivables
|
|
(1,959
|
)
|
|
(460
|
)
|
||
|
Prepaid income taxes
|
|
—
|
|
|
1,998
|
|
||
|
Prepaid expenses and other current assets
|
|
(112
|
)
|
|
(150
|
)
|
||
|
Intangibles and other assets
|
|
(99
|
)
|
|
(103
|
)
|
||
|
Accounts payable
|
|
4,286
|
|
|
1,935
|
|
||
|
Accrued compensation and other current liabilities
|
|
(2,902
|
)
|
|
(1,056
|
)
|
||
|
Deferred revenue
|
|
(2,929
|
)
|
|
(2,107
|
)
|
||
|
Other long-term liabilities
|
|
(50
|
)
|
|
(217
|
)
|
||
|
Net cash used in operating activities
|
|
(28,342
|
)
|
|
(11,488
|
)
|
||
|
Cash flows provided by investing activities:
|
|
|
|
|
||||
|
Purchases of short-term investments
|
|
(15,879
|
)
|
|
(19,886
|
)
|
||
|
Proceeds from maturities of short-term investments
|
|
20,000
|
|
|
24,000
|
|
||
|
Purchases of property and equipment
|
|
(110
|
)
|
|
(110
|
)
|
||
|
Proceeds for discontinued operations
|
|
—
|
|
|
1,000
|
|
||
|
Net cash provided by investing activities
|
|
4,011
|
|
|
5,004
|
|
||
|
Cash flows provided by financing activities:
|
|
|
|
|
||||
|
Issuance of common stock under employee stock purchase plan
|
|
175
|
|
|
128
|
|
||
|
Exercise of stock options
|
|
443
|
|
|
1,677
|
|
||
|
Net cash provided by financing activities
|
|
618
|
|
|
1,805
|
|
||
|
Net decrease in cash and cash equivalents
|
|
(23,713
|
)
|
|
(4,679
|
)
|
||
|
Cash and cash equivalents:
|
|
|
|
|
||||
|
Beginning of period
|
|
56,865
|
|
|
25,013
|
|
||
|
End of period
|
|
$
|
33,152
|
|
|
$
|
20,334
|
|
|
Supplemental disclosure of cash flow information
|
|
|
|
|
||||
|
Cash paid (received) for taxes
|
|
$
|
111
|
|
|
$
|
(473
|
)
|
|
Supplemental disclosure of noncash operating, investing, and financing activities
|
|
|
|
|
||||
|
Amounts accrued for property and equipment
|
|
$
|
3
|
|
|
$
|
8
|
|
|
Release of Restricted Stock Units and Awards under company stock plan
|
|
$
|
2,451
|
|
|
$
|
1,945
|
|
|
•
|
Persuasive evidence of an arrangement exists
. For a license arrangement, the Company requires a written contract, signed by both the customer and the Company.
|
|
•
|
Delivery has occurred
. The Company delivers software electronically. Delivery occurs when the Company provides the customer access codes or “keys” that allow the customer to take immediate possession of the software.
|
|
•
|
The fee is fixed or determinable
. The Company’s arrangement fee is based on the use of standard payment terms, which are those that are generally offered to the majority of customers. For transactions involving extended payment terms, the Company deems these fees not to be fixed or determinable for revenue recognition purposes and revenue is deferred until the fees become due and payable.
|
|
•
|
Collectability is probable.
To recognize revenue, the Company must judge collectability of fees, which is done on a customer-by-customer basis pursuant to the Company’s credit review policy. The Company typically sells to customers with whom there is a history of successful collection. For new customers, the Company evaluates the customer’s financial condition and ability to pay. If it is determined that collectability is not probable based upon the credit review process or the customer’s payment history, revenue is recognized when payment is received.
|
|
|
|
June 30, 2017
|
|
|
||||||||||||
|
|
|
Fair value measurements using
|
|
|
||||||||||||
|
|
|
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Total
|
||||||||
|
|
|
(In thousands)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury securities
|
|
$
|
—
|
|
|
$
|
28,863
|
|
|
$
|
—
|
|
|
$
|
28,863
|
|
|
Money market accounts
|
|
16,096
|
|
|
—
|
|
|
—
|
|
|
16,096
|
|
||||
|
Total assets at fair value
|
|
$
|
16,096
|
|
|
$
|
28,863
|
|
|
$
|
—
|
|
|
$
|
44,959
|
|
|
|
|
December 31, 2016
|
|
|
||||||||||||
|
|
|
Fair value measurements using
|
|
|
||||||||||||
|
|
|
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Total
|
||||||||
|
|
|
(In thousands)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury securities
|
|
$
|
—
|
|
|
$
|
32,907
|
|
|
$
|
—
|
|
|
$
|
32,907
|
|
|
Money market accounts
|
|
32,031
|
|
|
—
|
|
|
—
|
|
|
32,031
|
|
||||
|
Total assets at fair value
|
|
$
|
32,031
|
|
|
$
|
32,907
|
|
|
$
|
—
|
|
|
$
|
64,938
|
|
|
|
|
June 30, 2017
|
||||||||||||||
|
|
|
Amortized
Cost
|
|
Gross
Unrealized
Holding
Gains
|
|
Gross
Unrealized
Holding
Losses
|
|
Fair
Value
|
||||||||
|
|
|
(In thousands)
|
||||||||||||||
|
U.S. Treasury securities
|
|
$
|
28,894
|
|
|
$
|
—
|
|
|
$
|
(31
|
)
|
|
$
|
28,863
|
|
|
Total
|
|
$
|
28,894
|
|
|
$
|
—
|
|
|
$
|
(31
|
)
|
|
$
|
28,863
|
|
|
|
|
December 31, 2016
|
||||||||||||||
|
|
|
Amortized
Cost
|
|
Gross
Unrealized
Holding
Gains
|
|
Gross
Unrealized
Holding
Losses
|
|
Fair
Value
|
||||||||
|
|
|
(In thousands)
|
||||||||||||||
|
U.S. Treasury securities
|
|
$
|
32,914
|
|
|
$
|
—
|
|
|
$
|
(7
|
)
|
|
$
|
32,907
|
|
|
Total
|
|
$
|
32,914
|
|
|
$
|
—
|
|
|
$
|
(7
|
)
|
|
$
|
32,907
|
|
|
|
|
June 30, 2017
|
|
December 31, 2016
|
||||
|
|
|
(In thousands)
|
||||||
|
Trade accounts receivable
|
|
$
|
2,931
|
|
|
$
|
1,084
|
|
|
Receivables from vendors and other
|
|
404
|
|
|
298
|
|
||
|
Accounts and other receivables
|
|
$
|
3,335
|
|
|
$
|
1,382
|
|
|
|
|
June 30, 2017
|
|
December 31, 2016
|
||||
|
|
|
(In thousands)
|
||||||
|
Computer equipment and purchased software
|
|
$
|
3,539
|
|
|
$
|
3,489
|
|
|
Machinery and equipment
|
|
866
|
|
|
882
|
|
||
|
Furniture and fixtures
|
|
1,295
|
|
|
1,290
|
|
||
|
Leasehold improvements
|
|
3,969
|
|
|
3,917
|
|
||
|
Total
|
|
9,669
|
|
|
9,578
|
|
||
|
Less accumulated depreciation
|
|
(6,031
|
)
|
|
(5,562
|
)
|
||
|
Property and equipment, net
|
|
$
|
3,638
|
|
|
$
|
4,016
|
|
|
|
|
June 30, 2017
|
|
December 31, 2016
|
||||
|
|
|
(In thousands)
|
||||||
|
Purchased patents and other purchased intangible assets
|
|
$
|
4,605
|
|
|
$
|
4,605
|
|
|
Less: Accumulated amortization of purchased patents and other purchased intangibles
|
|
(4,605
|
)
|
|
(4,605
|
)
|
||
|
Purchased patents and other purchased intangible assets, net
|
|
—
|
|
|
—
|
|
||
|
Other assets
|
|
363
|
|
|
365
|
|
||
|
Intangibles and other assets, net
|
|
$
|
363
|
|
|
$
|
365
|
|
|
|
|
June 30, 2017
|
|
December 31, 2016
|
||||
|
|
|
(In thousands)
|
||||||
|
Accrued legal
|
|
$
|
2,378
|
|
|
$
|
3,096
|
|
|
Accrued services
|
|
502
|
|
|
473
|
|
||
|
Income taxes payable
|
|
292
|
|
|
164
|
|
||
|
Other current liabilities
|
|
714
|
|
|
676
|
|
||
|
Total other current liabilities
|
|
$
|
3,886
|
|
|
$
|
4,409
|
|
|
|
June 30, 2017
|
|
|
Common stock shares available for grant
|
2,907,654
|
|
|
Standard and market condition stock options outstanding
|
3,879,034
|
|
|
Restricted stock awards outstanding
|
44,538
|
|
|
RSU's outstanding
|
641,320
|
|
|
|
|
||
|
|
Six Months Ended June 30, 2017
|
||
|
Shares purchased under ESPP
|
27,667
|
|
|
|
Average price of shares purchased under ESPP
|
$
|
6.34
|
|
|
Intrinsic value of shares purchased under ESPP
|
$
|
109,000
|
|
|
|
|
Six Months Ended June 30, 2017
|
||
|
Beginning outstanding balance
|
|
3,421,121
|
|
|
|
Granted
|
|
262,338
|
|
|
|
Exercised
|
|
(58,023
|
)
|
|
|
Forfeited
|
|
(56,724
|
)
|
|
|
Expired
|
|
(35,508
|
)
|
|
|
Ending outstanding balance
|
|
3,533,204
|
|
|
|
Aggregate intrinsic value of options exercised
|
|
$
|
134,000
|
|
|
Weighted average fair value of options granted
|
|
3.98
|
|
|
|
|
|
Number of
Shares
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Contractual
Life (years)
|
|
Aggregate
Intrinsic
Value
(in millions)
|
|||||
|
June 30, 2017
|
|
|
|
|
|
|
|
|
|||||
|
Options outstanding
|
|
3,533,204
|
|
|
$
|
8.47
|
|
|
3.73
|
|
$
|
4.8
|
|
|
Options vested and expected to vest using estimated forfeiture rates
|
|
3,358,207
|
|
|
8.45
|
|
|
3.62
|
|
4.7
|
|
||
|
Options exercisable
|
|
2,388,508
|
|
|
8.31
|
|
|
2.84
|
|
4.0
|
|
||
|
|
|
Six Months Ended June 30, 2017
|
||
|
Beginning outstanding balance
|
|
225,000
|
|
|
|
Granted
|
|
120,830
|
|
|
|
Exercised
|
|
—
|
|
|
|
Canceled
|
|
—
|
|
|
|
Ending outstanding balance
|
|
345,830
|
|
|
|
Aggregate intrinsic value of options exercised
|
|
$
|
—
|
|
|
|
|
Number of
Shares
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Contractual
Life (years)
|
|
Aggregate
Intrinsic
Value
(in millions)
|
|||||
|
June 30, 2017
|
|
|
|
|
|
|
|
|
|||||
|
Options outstanding
|
|
345,830
|
|
|
$
|
8.48
|
|
|
5.67
|
|
$
|
—
|
|
|
Options vested and expected to vest using estimated forfeiture rates
|
|
318,584
|
|
|
8.47
|
|
|
5.62
|
|
—
|
|
||
|
Options exercisable
|
|
84,375
|
|
|
8.09
|
|
|
4.67
|
|
—
|
|
||
|
|
|
Six Months Ended June 30, 2017
|
||
|
Beginning outstanding balance
|
|
427,192
|
|
|
|
Awarded
|
|
431,015
|
|
|
|
Released
|
|
(173,058
|
)
|
|
|
Forfeited
|
|
(43,829
|
)
|
|
|
Ending outstanding balance
|
|
641,320
|
|
|
|
Weighted average grant date fair value of RSUs granted
|
|
$
|
8.47
|
|
|
Total fair value of RSUs released
|
|
1,781,000
|
|
|
|
|
|
Number of
Shares
|
|
Weighted
Average
Remaining
Contractual
Life (years)
|
|
Aggregate
Intrinsic
Value
(in millions)
|
|||
|
June 30, 2017
|
|
|
|
|
|
|
|||
|
RSUs outstanding
|
|
641,320
|
|
|
1.62
|
|
$
|
5.8
|
|
|
RSUs vested and expected to vest using estimated forfeiture rates
|
|
498,283
|
|
|
1.51
|
|
4.5
|
|
|
|
|
|
Six Months Ended June 30, 2017
|
||
|
Beginning outstanding balance
|
|
77,540
|
|
|
|
Awarded
|
|
44,538
|
|
|
|
Released
|
|
(77,540
|
)
|
|
|
Forfeited
|
|
—
|
|
|
|
Ending outstanding balance
|
|
44,538
|
|
|
|
Weighted average grant date fair value of restricted stock awarded
|
|
$
|
8.65
|
|
|
Total fair value of restricted stock awards released
|
|
671,000
|
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||
|
Standard Stock Options
|
|
|
|
|
|
|
|
|
||||
|
Expected life (in years)
|
|
4.6
|
|
|
4.5
|
|
|
4.5
|
|
|
4.5
|
|
|
Volatility
|
|
53
|
%
|
|
55
|
%
|
|
53
|
%
|
|
55
|
%
|
|
Interest rate
|
|
1.7
|
%
|
|
1.1
|
%
|
|
1.7
|
%
|
|
1.2
|
%
|
|
Dividend yield
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
|||||||
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
|||
|
Market Condition Based Stock Options
|
|
|
|
|
|
|
|
|
|||
|
Expected life (in years)
|
|
7.0
|
|
|
N/A
|
|
7.0
|
|
|
7.0
|
|
|
Volatility
|
|
55
|
%
|
|
N/A
|
|
55
|
%
|
|
59
|
%
|
|
Interest rate
|
|
2.0
|
%
|
|
N/A
|
|
2.0
|
%
|
|
1.6
|
%
|
|
Dividend yield
|
|
N/A
|
|
|
N/A
|
|
N/A
|
|
|
N/A
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||
|
Employee Stock Purchase Plan
|
|
|
|
|
|
|
|
|
||
|
Expected life (in years)
|
|
N/A
|
|
N/A
|
|
0.5
|
|
|
0.5
|
|
|
Volatility
|
|
N/A
|
|
N/A
|
|
50
|
%
|
|
53
|
%
|
|
Interest rate
|
|
N/A
|
|
N/A
|
|
0.7
|
%
|
|
0.5
|
%
|
|
Dividend yield
|
|
N/A
|
|
N/A
|
|
N/A
|
|
|
N/A
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
|
|
(In thousands)
|
||||||||||||||
|
Statement of Operations Classifications
|
|
|
|
|
|
|
|
|
||||||||
|
Sales and marketing
|
|
$
|
281
|
|
|
$
|
332
|
|
|
$
|
491
|
|
|
$
|
560
|
|
|
Research and development
|
|
213
|
|
|
258
|
|
|
549
|
|
|
784
|
|
||||
|
General and administrative
|
|
684
|
|
|
665
|
|
|
1,695
|
|
|
2,245
|
|
||||
|
Total
|
|
$
|
1,178
|
|
|
$
|
1,255
|
|
|
$
|
2,735
|
|
|
$
|
3,589
|
|
|
|
|
Six Months Ended June 30, 2017
|
||||||||||
|
|
|
Unrealized Gains
and Losses on
Short-term Investments
|
|
Foreign
Currency
Items
|
|
Total
|
||||||
|
|
|
(In thousands)
|
||||||||||
|
Beginning balance
|
|
$
|
(7
|
)
|
|
$
|
122
|
|
|
$
|
115
|
|
|
Other comprehensive income before reclassifications
|
|
(24
|
)
|
|
—
|
|
|
(24
|
)
|
|||
|
Amounts reclassified from accumulated other comprehensive income
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Net current period other comprehensive income
|
|
(24
|
)
|
|
—
|
|
|
(24
|
)
|
|||
|
Ending Balance
|
|
$
|
(31
|
)
|
|
$
|
122
|
|
|
$
|
91
|
|
|
|
|
Three Months Ended June 30,
|
|
Six Months Ended June 30,
|
||||||||||||
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
|
|
|
|
|
|
|
||||||||||
|
Loss from continuing operations before benefit (provision) for income taxes
|
|
$
|
(14,746
|
)
|
|
$
|
(9,528
|
)
|
|
$
|
(27,459
|
)
|
|
$
|
(13,924
|
)
|
|
Benefit (provision) for income taxes
|
|
(99
|
)
|
|
3,323
|
|
|
(251
|
)
|
|
5,024
|
|
||||
|
Effective tax rate
|
|
(0.7
|
)%
|
|
34.9
|
%
|
|
(0.9
|
)%
|
|
36.1
|
%
|
||||
|
|
|
Three months ended June 30,
|
|
Six months ended June 30,
|
||||||||||||
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
|
|
|
(in thousands, except
per share amounts)
|
||||||||||||||
|
Numerator:
|
|
|
|
|
|
|
|
|
||||||||
|
Loss from continuing operations
|
|
$
|
(14,845
|
)
|
|
$
|
(6,205
|
)
|
|
$
|
(27,710
|
)
|
|
$
|
(8,900
|
)
|
|
Income from discontinued operations, net of tax
|
|
—
|
|
|
649
|
|
|
—
|
|
|
649
|
|
||||
|
Net loss
|
|
$
|
(14,845
|
)
|
|
$
|
(5,556
|
)
|
|
$
|
(27,710
|
)
|
|
$
|
(8,251
|
)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
||||||||
|
Shares used in computation of basic and diluted net loss per share (weighted average common shares outstanding)
|
|
29,193
|
|
|
28,834
|
|
|
29,109
|
|
|
28,663
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
||||||||
|
Continuing operations
|
|
(0.51
|
)
|
|
(0.22
|
)
|
|
(0.95
|
)
|
|
(0.31
|
)
|
||||
|
Discontinued operations
|
|
—
|
|
|
0.02
|
|
|
—
|
|
|
0.02
|
|
||||
|
Total
|
|
$
|
(0.51
|
)
|
|
$
|
(0.20
|
)
|
|
$
|
(0.95
|
)
|
|
$
|
(0.29
|
)
|
|
|
June 30,
|
||||
|
|
2017
|
|
2016
|
||
|
Standard and market condition stock options outstanding
|
3,879,034
|
|
|
3,521,481
|
|
|
Restricted stock awards outstanding
|
44,538
|
|
|
77,540
|
|
|
RSUs outstanding
|
641,320
|
|
|
510,234
|
|
|
ESPP
|
22,604
|
|
|
27,670
|
|
|
|
|
June 30,
|
|
Change
|
|
% Change
|
|||||||||
|
REVENUES
|
|
2017
|
|
2016
|
|
|
|
|
|||||||
|
|
|
(In thousands)
|
|
|
|
|
|||||||||
|
Three months ended:
|
|
|
|
|
|
|
|
|
|||||||
|
Royalty and license
|
|
$
|
6,785
|
|
|
$
|
7,615
|
|
|
$
|
(830
|
)
|
|
(11
|
)%
|
|
Development, services, and other
|
|
245
|
|
|
249
|
|
|
(4
|
)
|
|
(2
|
)%
|
|||
|
Total Revenues
|
|
$
|
7,030
|
|
|
$
|
7,864
|
|
|
$
|
(834
|
)
|
|
(11
|
)%
|
|
Six months ended:
|
|
|
|
|
|
|
|
|
|||||||
|
Royalty and license
|
|
$
|
15,791
|
|
|
$
|
21,063
|
|
|
$
|
(5,272
|
)
|
|
(25
|
)%
|
|
Development, services, and other
|
|
463
|
|
|
424
|
|
|
39
|
|
|
9
|
%
|
|||
|
Total Revenues
|
|
$
|
16,254
|
|
|
$
|
21,487
|
|
|
$
|
(5,233
|
)
|
|
(24
|
)%
|
|
|
|
June 30,
|
|
Change
|
|
% Change
|
|||||||||
|
OPERATING EXPENSES
|
|
2017
|
|
2016
|
|
|
|
|
|||||||
|
|
|
(Dollars in thousands)
|
|
|
|
|
|||||||||
|
Three months ended:
|
|
|
|
|
|
|
|
|
|||||||
|
Sales and marketing
|
|
$
|
3,461
|
|
|
$
|
3,397
|
|
|
$
|
64
|
|
|
2
|
%
|
|
% of total revenue
|
|
49
|
%
|
|
43
|
%
|
|
6
|
%
|
|
|
||||
|
Research and development
|
|
$
|
2,826
|
|
|
$
|
2,966
|
|
|
$
|
(140
|
)
|
|
(5
|
)%
|
|
% of total revenue
|
|
40
|
%
|
|
38
|
%
|
|
2
|
%
|
|
|
||||
|
General and administrative
|
|
$
|
15,600
|
|
|
$
|
11,001
|
|
|
$
|
4,599
|
|
|
42
|
%
|
|
% of total revenue
|
|
222
|
%
|
|
140
|
%
|
|
82
|
%
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|||||||
|
Six months ended:
|
|
|
|
|
|
|
|
|
|||||||
|
Sales and marketing
|
|
$
|
6,766
|
|
|
$
|
7,200
|
|
|
$
|
(434
|
)
|
|
(6
|
)%
|
|
% of total revenue
|
|
42
|
%
|
|
34
|
%
|
|
8
|
%
|
|
|
||||
|
Research and development
|
|
$
|
6,022
|
|
|
$
|
7,278
|
|
|
$
|
(1,256
|
)
|
|
(17
|
)%
|
|
% of total revenue
|
|
37
|
%
|
|
34
|
%
|
|
3
|
%
|
|
|
||||
|
General and administrative
|
|
$
|
31,132
|
|
|
$
|
21,091
|
|
|
$
|
10,041
|
|
|
48
|
%
|
|
% of total revenue
|
|
192
|
%
|
|
98
|
%
|
|
94
|
%
|
|
|
||||
|
|
|
June 30,
|
|
Change
|
|
% Change
|
|||||||||
|
BENEFIT (PROVISION) FOR TAXES
|
|
2017
|
|
2016
|
|
|
|
|
|||||||
|
|
|
(Dollars in thousands)
|
|
|
|
|
|||||||||
|
Three months ended:
|
|
|
|
|
|
|
|
|
|||||||
|
Benefit (provision) for income taxes
|
|
$
|
(99
|
)
|
|
$
|
3,323
|
|
|
$
|
(3,422
|
)
|
|
(103
|
)%
|
|
Loss from continuing operations before benefit (provision) for income taxes
|
|
(14,746
|
)
|
|
(9,528
|
)
|
|
|
|
|
|||||
|
Effective tax rate
|
|
(0.7
|
)%
|
|
34.9
|
%
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|||||||
|
Six months ended:
|
|
|
|
|
|
|
|
|
|||||||
|
Benefit (provision) for income taxes
|
|
$
|
(251
|
)
|
|
$
|
5,024
|
|
|
$
|
(5,275
|
)
|
|
(105
|
)%
|
|
Loss from continuing operations before benefit (provision) for income taxes
|
|
(27,459
|
)
|
|
(13,924
|
)
|
|
|
|
|
|||||
|
Effective tax rate
|
|
(0.9
|
)%
|
|
36.1
|
%
|
|
|
|
|
|||||
|
•
|
difficulties in persuading device manufacturers to take a license or renew a license to our intellectual property without the expenditure of significant resources;
|
|
•
|
difficulties in persuading existing customers that they still need a license to the portfolio as individual patents expire or become limited in scope, declared unenforceable or invalidated;
|
|
•
|
reluctance of device manufacturers to take a license or renew a license to our intellectual property because other larger device manufacturers are not licensed;
|
|
•
|
difficulties in entering into or renewing gaming licenses if video game console makers choose not to license third parties to make peripherals for their new consoles, if video console makers no longer require peripherals to play video games, if video console makers no longer utilize technology in the peripherals that are covered by our patents or if the overall market for video consoles deteriorates substantially;
|
|
•
|
reluctance of content developers or distributors, mobile device manufacturers, and service providers to sign license agreements without a critical mass of other such inter-dependent supporters of the mobile device industry also having a license, or without enough similar devices in the market that incorporate our technologies;
|
|
•
|
the competition we may face from third parties and/or the internal design teams of existing and potential licensees;
|
|
•
|
difficulties in achieving and maintaining consumer and market demand or acceptance for our products;
|
|
•
|
difficulties in persuading third parties to work with us, to rely on us for critical technology, and to disclose to us proprietary product development and other strategies;
|
|
•
|
difficulties in persuading existing licensees who compensate us for including our software in certain of their touch-enabled products to also license and compensate us for our patents that cover other touch-enabled products of theirs that do not include our software;
|
|
•
|
challenges in demonstrating the compelling value of our technologies and challenges associated with customers’ ability to easily implement our technologies; and
|
|
•
|
inability of current or prospective licensees to ship certain devices if they are involved in IP infringement claims by third parties that ultimately prevent them from shipping products or that impose substantial royalties on their products;
|
|
•
|
our pending patent applications may not result in the issuance of patents;
|
|
•
|
our patents may not be broad enough to protect our proprietary rights;
|
|
•
|
effective patent protection may not be available in every country, particularly in Asia, where we or our licensees do business; and
|
|
•
|
our pending litigation against Apple and AT&T Mobility, Samsung, and Motorola, may be unsuccessful or may result in one or more of the patents asserted becoming limited in scope, declared unenforceable or invalidated.
|
|
•
|
laws and contractual restrictions may not be sufficient to prevent misappropriation of our technologies or deter others from developing similar technologies; and
|
|
•
|
policing unauthorized use of our patented technologies, trademarks, and other proprietary rights would be difficult, expensive, and time-consuming, within and particularly outside of the United States.
|
|
•
|
compliance with multiple, conflicting and changing governmental laws and regulations;
|
|
•
|
laws and business practices favoring local competitors;
|
|
•
|
foreign exchange and currency risks;
|
|
•
|
changing import and export restrictions, duties, tariffs, quotas and other barriers;
|
|
•
|
difficulties staffing and managing foreign operations;
|
|
•
|
difficulties and expense in establishing and enforcing IP rights;
|
|
•
|
business risks, including fluctuations in demand for our technologies and products and the cost and effort to conduct international operations and travel abroad to promote international distribution and overall global economic conditions;
|
|
•
|
multiple conflicting tax laws and regulations;
|
|
•
|
political and economic instability; and
|
|
•
|
the possibility of an outbreak of hostilities or unrest in markets where major customers are located, including Korea.
|
|
•
|
incur costs related to litigation;
|
|
•
|
increase our sales and marketing efforts;
|
|
•
|
engage in research and develop our technologies; and
|
|
•
|
protect and enforce our IP;
|
|
•
|
the establishment or loss of licensing relationships;
|
|
•
|
the timing and recognition of payments under fixed and/or up-front license agreements, as well as other multi-element arrangements;
|
|
•
|
seasonality in the demand for our technologies or products or our licensees’ products;
|
|
•
|
the timing of our expenses, including costs related to litigation, stock-based awards, acquisitions of technologies, or businesses;
|
|
•
|
developments in and costs of pursuing or settling any pending litigation;
|
|
•
|
the timing of introductions and market acceptance of new technologies and products and product enhancements by us, our licensees, our competitors, or their competitors;
|
|
•
|
the timing of work performed under development agreements; and
|
|
•
|
errors in our licensees’ royalty reports, and corrections and true-ups to royalty payments and royalty rates from prior periods.
|
|
•
|
our board of directors is classified into three classes of directors with staggered three-year terms which will be phased out over time through 2019;
|
|
•
|
only our chairperson of the board of directors, a majority of our board of directors or 10% or greater stockholders are authorized to call a special meeting of stockholders;
|
|
•
|
our stockholders can only take action at a meeting of stockholders and not by written consent;
|
|
•
|
vacancies on our board of directors can be filled only by our board of directors and not by our stockholders;
|
|
•
|
our restated certificate of incorporation authorizes undesignated preferred stock, the terms of which may be established and shares of which may be issued without stockholder approval; and
|
|
•
|
advance notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders.
|
|
•
|
unanticipated costs associated with the acquisitions;
|
|
•
|
use of substantial portions of our available cash to consummate the acquisitions;
|
|
•
|
diversion of management’s attention from other business concerns;
|
|
•
|
difficulties in assimilation of acquired personnel or operations;
|
|
•
|
failure to realize the anticipated benefits of acquired IP or other assets;
|
|
•
|
charges associated with amortization of acquired assets or potential charges for write-down of assets or goodwill associated with unsuccessful acquisitions;
|
|
•
|
potential IP infringement or other claims related to acquired businesses, assets, product lines, or technologies; and
|
|
•
|
potential costs associated with failed acquisition efforts.
|
|
|
|
|
|
|
IMMERSION CORPORATION
|
|
|
|
|
|
|
|
By
|
/s/ Nancy Erba
|
|
|
|
Nancy Erba
|
|
|
|
Chief Financial Officer and Principal Accounting Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
Incorporated by Reference
|
|
Filed
Herewith
|
||||||
|
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
101.INS
|
|
XBRL Report Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.CAL
|
|
XBRL Taxonomy Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.LAB
|
|
XBRL Taxonomy Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.PRE
|
|
XBRL Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
*
|
This certification is deemed not filed for purposes of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|